DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors in vitro

Eliza Mari Kwesi‐Maliepaard(The Netherlands Cancer Institute), Fred van Leeuwen(The Netherlands Cancer Institute)
Frontiers in Genetics
November 8, 2022
Cited by 5


Related Papers